Repeated cocaine administration down-regulates glucocorticoid receptors in the rat brain cortex and hippocampus

Polish Journal of Pharmacology

Volumn 48, Issue 6, 1996, Pages 575-581

  Budziszewska, Bogusława ^a   Leśkiewicz, Monika ^a   Jaworska Feil, Lucylla ^a   Lasoń, Władysław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

cocaine; frontal cortex; glucocorticoid receptors; hippocampus; Western blot

Indexed keywords

COCAINE; GLUCOCORTICOID RECEPTOR; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; FEEDBACK SYSTEM; FRONTAL CORTEX; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOBLOTTING; INTRAPERITONEAL DRUG ADMINISTRATION; LONG TERM EXPOSURE; MALE; NONHUMAN; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION;

EID: 0030424201     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. 7 human breast cancer cells. Cancer Res., 1981, 41, 4720-4726.
2. Antakly T., Mercille S., Cote J. P.: Tissue-specific dopaminergic regulation of the glucocorticoid receptor in the rat pituitary. Endocrinology, 1987, 120, 1558-1562.
3. Borowsky B., Kuhn C. M.: Chronic cocaine administration sensitizes behavioral but not neuroendocrine responses. Brain Res., 1991, 543, 301-306.
4. Brooke S. M., de Haas-Johnson A. M., Kaplan J. R., Sapolsky R. M.: Characterization of mineralocorticoid and glucocorticoid receptors in primate brain. Brain Res., 1994, 637, 303-307.
5. Budziszewska B., Jaworska-Feil L., Lasoń W.: Repeated amphetamine administration down-regulates glucocorticoid, but not mineralocorticoid, receptors in the rat hippocampus. Pol. J. Pharmacol., 1995, 47, 401-406.
6. Budziszewska B., Jaworska-Feil L., Lasoń W.: The effect of repeated amphetamine and cocaine administration on adrenal, gonadal and thyroid hormone levels in the rat plasma. Exp. Clin. Endocrinol. Diabetes, 1996, 104, 334-338.
7. Budziszewska B., Lasoń W: Pharmacological modulation of glucocorticoid and mineralocorticoid receptors in the rat central nervous system. Pol. J. Pharmacol., 1994, 46, 97-102.
8. Budziszewska B., Siwanowicz J., Przegaliński E.: The effect of chronic treatment with antidepressant drugs on the corticosteroid receptor levels in the rat hippocampus. Pol. J. Pharmacol., 1994, 46, 147-152.
9. Casolini P., Piazza P. V., Kabbaj M., Leprat F., Angelucci L., Simon H., Le Moal M., Maccari S.: The mesolimbic dopaminergic system exerts an inhibitory influence on brain corticosteroid receptor affinities. Neuroscience, 1993, 55, 429-434.
10. De Kloet E. R.: Brain corticosteroid receptor balance and homeostatic control. Front. Neuroendocrinol., 1990, 12, 95-164.
11. Deroche V., Piazza P. V., Maccari S., Le Moal M., Simon H.: Repeated corticosterone administration sensitizes the locomotor response to amphetamine. Brain Res., 1992, 584, 309-313.
12. Deroche V., Piazza P. V., Casolini P., Maccari S., Le Moal M., Simon H.: Stress-induced sensitization to amphetamine and morphine psychomotor effects depends on stress-induced corticosterone secretion. Brain Res., 1992, 598, 343-348.
13. Dong Y., Poellinger L., Gustafsson J.-A., Okret S.: Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms. Mol. Endocrinol., 1988, 2, 1256-1264.
14. Kleber H. D., Gawin F. H.: Cocaine abuse: a review of current and experimental treatments. In: Cocaine: Pharmacology, Effects, and Treatment of Abuse. Ed. Grabowski J., NIDA Research Monograph 50, 1984, 111-129.
15. Lowry O. H., Rosenbrough N. J., Farr A. L., Randall R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem., 1951, 193, 265-275.
16. Lowy M. T.: MK-801 antagonizes methamphetamineinduced decreases in hippocampal and striatal corticosteroid receptors. Brain Res., 1990, 533, 348-352.
17. Lowy M. T., Nash J. F., Meltzer H. Y.: Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA). Eur. J. Pharmacol., 1989, 163, 157-161.
18. Lowy M. T., Novotney S.: Methamphetamine-induced decrease in neural glucocorticoid receptors: relationship to monoamine levels. Brain Res., 1994, 638, 175-181.
19. Maccari S., Piazza P. W., Deminiere J. M., Angeluci L., Simon H., Le Moal M.: Hippocampal type I and type II corticosteroid receptor affinities are reduced in rats predisposed to develop amphetamine self-administration. Brain Res., 1991, 548, 305-309.
20. Marinelli M., Piazza P. V., Deroche V., Maccari S., Le Moal M., Simon H.: Corticosterone circadian secretion differentially facilitates dopamine-mediated psychomotor effect of cocaine and morphine. J. Neurosci., 1994, 14, 2724-2731.
21. Mitchell J. B., Rowe W., Boksa P., Meaney M. J.: Serotonin regulates type II corticosteroid receptor binding in hippocampal cell cultures. J. Neurosci., 1990, 10, 1745-1752.
22. O'Donnell D., Francis D., Weaver S., Meaney M. J.: Effects of adrenalectomy and corticosterone replacement on glucocorticoid receptor levels in rat brain tissue: a comparison between Western blotting and receptor binding assays. Brain Res., 1995, 687, 133-142.
23. Okret S., Wikström A.-C., Wrange Ö., Andersson B., Gustafsson J.-Å.: Monoclonal antibodies against the rat liver glucocorticoid receptor. Proc. Nat. Acad. Sci. USA, 1984, 81, 1609-1613.
24. Peiffer A., Veilleux S., Barden N.: Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology, 1991, 16, 505-515.
25. Pepin M-C., Govindan M. V., Barden N.: Increased glucocorticoid receptor gene promoter activity after antidepressant treatment. Mol. Pharmacol., 1992, 41, 1016-1022.
26. Piazza P. V., Marinelli M., Jodogne C., Deroche V., Rouge-Pont F., Maccari S., Le-Moal M., Simon H.: Inhibition of corticosterone synthesis by metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res., 1994, 658, 259-264.
27. Przegaliński E., Budziszewska B.: The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats. Neurosci. Lett, 1993, 161, 215-218.
28. Ratka A., Sutanto W., Blomers M., deKloet E. R.: On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology, 1989, 50, 117-123.
29. Rivet J. M., Stinus L., Le Moal M., Mormede P.: Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation. Brain Res., 1989, 498, 149-153.
30. Rouge-Pont F., Marinelli M., Le Moal M., Simon H., Piazza P. V.: Stress-induced sensitization and glucocorticoids. II. Sensitization of the increase in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion. J. Neurosci., 1995, 15, 7189-7195.
31. Sapolsky R. M., Armanini M. P., Packan D. R., Sutton S. W., Plotsky P. M.: Glucocorticoid feedback inhibition of adrenocorticotroptc hormone secrctagogue release. Neuroendocrinology, 1990, 51, 328-336.
32. Sapolsky R. M., Krey L. C., McEwen B. S.: Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology, 1984, 114, 287-309.
33. Sapolsky R. M., McEwen B. S.: Down-regulation of neural corticosterone receptors by corticosterone and dexamethasone. Brain Res., 1985, 339, 161-165.
34. Seckl J. R., Fink G.: Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology, 1992, 55, 621-626.
35. Shilling P. D., Kelsoe J. R., Segal D. S.: Hippocampal glucocorticoid receptor mRNA is up-regulated by acute and down-regulaled by chronic amphetamine treatment. Mol. Brain Res., 1996, 38, 156-160.
36. Spangler R., Unterwald E. M., Kreek M. J.: "Binge" cocaine administration induced a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol. Brain Res., 1993, 19, 323-327.